Instruction For The Authors



Call for abstracts
All participants are invited to submit an abstract on the topics listed for presentation at the 9th ECC and 16th MCC Congress.

Abstracts may be submitted online or as an attachment to your e-mail sent to the Congress Organizing Secretariat. The deadline for submission of abstracts is 1 August, 2008.

Each first author may submit maximum two abstracts.

Online Submission
Please click for online abstract form and follow the instruction to submit your abstract. If online submission is not possible please send your abstract form as an attachment to your e-mail. Avoid sending your abstract within the last 3-4 days of the deadline. Abstractform is available on the web site only.

Notification
After review of the abstracts by the Scientific Programme Committee, the corresponding author will be notified by 15 August, 2008. If notification is not received by then, the Congress Secretariat can be contacted.

Poster/Oral Presentation
Accepted abstracts are to be presented either as poster or oral presentations. The final presentation format will be decided by the Scientific Programme Committee. Instructions concerning the preparation format of the presentation will be given in the acceptance mail by 15 August, 2008

Publication
Abstracts will be published as a CD-ROM, before the Congress

Registration
All presenters of abstracts must register until 15 September 2008 to take advantage of the early registration fee or advise us of their withdrawal by that date. Only abstracts with registered participants will be included in the CD ROM to be produced before the Congress.

Poster Sessions
Posters will be displayed during the Conference according to schedule. One of the authors of each poster should be present at least for one hour during the requested time allotment. Details on poster sizes, etc will be given in due course.



TOPICS on ORAL and POSTER PRESENTATIONS

A) ANTIMICROBIAL SECTION

A1. European streptococcal infections
A2. Bone and joint infections
A3. Device infections, local infections
A4. Brucellosis
A5. Leptospirosis
A6. Rickettsiosis
A7. Leishmaniasis
A8. Avian flu
A9. HIV infection and other viral diseases
A10. Tuberculosis
A11. Malaria
A12. Pharmacodynamics and pharmacokinetics of antimicrobial drugs
A13. MRSA
A14. Infections in the ICU
A15. Resistant Gram negative bacteria
A16. Fungal infections
A17. New vaccines
A18. Immunology
A19. Infection control in developing countries
A20. Infection in immunocompromised patient
A21. Infections in thalassemic patients
A22. Antibiotic resistance and its reversal
A23. Beta-lactams
A24. Quinolones
A25. Other anti-bacterials
A26. Anti-viral agents
A27. New compounds
A28. Surgical infections
A29. Other clinical infections
A30. Hospital infections
A31. Miscellaneous


B) CANCER SECTION

B1. Signaling pathways in cancer cell B24. Cancer of lung 
B2. Growth factors signaling B25. Gastric cancer 
B3. Apoptosis B26. Colorectal cancer 
B4. New drugs targeting P53 pathway B27. Cancer of prostate 
B5. Tyrosine - kinase inhibitors B28. Head and neck cancer
B6. Antiangiogenic cancer treatment B29. Cancer of the bladder
B7. Monoclonal antibodies in cancer treatment B30. Renal cell carcinoma 
B8.  Epigenetic modifier drugs in cancer treatment B31. Ovarian cancer 
B9. Pharmacogenomic markers B32. Uterine cancer
B10.Pharmacodynamics and pharmacokinetics B33. Testicular cancer
       in  cancer treatment B34. Tumors of central nervous system
B11. Tumor vaccines  B35. Malignant melanoma
B12. Immunotherapy B36. Lymphomas
B13. Carcinogens  B37. Leukemias
B14. RNA interference  B38. Multiple myeloma
B15. Cancer and thrombosis B39. Pediatric tumors
B16. Inflammation and cancer B40. Sarcomas 
B17. Stem cells  B41. Blood and marrow
        transplantation
B18. Infectious agents as etiology in cancer  B42. Oncologic emergencies
B19. Infections in cancer  B43. Palliative care
B20. Prevention of cancer  B44. Pain management and
        symptom control 
B21. Genetic basis for cancer diagnosis  B45. Epidemiology
B22. Genetic basis for cancer treatment B46. Miscellaneous
B23. Cancer of breast   


Verus Welcome Address - Important Dates - Important Addresses - Committees - Exhibition - Introduction to the Scientific Programme - Congress Overview - Scientific Programme - Instruction for Authors/ Abstract Form - Registration - Accommodation - Congress Venue Overview - General Information - Istanbul - Social / Cultural Events - Tours - Istanbul City Maps - Contact Us